The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review

Agrawal, 2013, Dendritic cells from the elderly display an intrinsic defect in the production of IL-10 in response to lithium chloride, Exp. Gerontol., 48, 1285, 10.1016/j.exger.2013.08.006 Barbosa, 2011, Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder, Eur. Arch. psychiatry Clin. Neurosci., 261, 139, 10.1007/s00406-010-0116-z Bauer, 2013, Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data, Int. J. bipolar Disord., 1, 5, 10.1186/2194-7511-1-5 Becking, 2015, Inflammatory monocyte gene expression: trait or state marker in bipolar disorder?, Int. J. bipolar Disord., 3, 20, 10.1186/s40345-015-0037-x Beumer, 2012, The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes, J. Leukoc. Biol., 92, 959, 10.1189/jlb.0212100 Boufidou, 2004, Cytokine production in bipolar affective disorder patients under lithium treatment, J. Affect. Disord., 82, 309, 10.1016/j.jad.2004.01.007 Breunis, 2003, High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder, Biol. psychiatry, 53, 157, 10.1016/S0006-3223(02)01452-X Carmen, 1993, The effects of lithium therapy on leukocytes: a 1-year follow-up study, J. Natl. Med. Assoc., 85, 301 Cetin, 2012, Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms, BMC Psychiatry, 12, 158, 10.1186/1471-244X-12-158 Cipriani, 2011, Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis, Lancet, 378, 1306, 10.1016/S0140-6736(11)60873-8 Cunha, 2008, Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder, Eur. Arch. Psychiatry Clin. Neurosci., 258, 300, 10.1007/s00406-007-0797-0 Dickerson, 2007, Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 31, 952, 10.1016/j.pnpbp.2007.02.018 Diez-Ruiz, 1995, Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis, Eur. J. Haematol., 54, 1, 10.1111/j.1600-0609.1995.tb01618.x Drexhage, 2010, The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder, Expert Rev. Neurother., 10, 59, 10.1586/ern.09.144 Drzyzga, 2006, Cytokines in schizophrenia and the effects of antipsychotic drugs, Brain Behav. Immun., 20, 532, 10.1016/j.bbi.2006.02.002 Fiedorowicz, 2015, Peripheral inflammation during abnormal mood states in bipolar I disorder, J. Affect. Disord., 187, 172, 10.1016/j.jad.2015.08.036 Geddes, 2013, Treatment of bipolar disorder, Lancet, 381, 1672, 10.1016/S0140-6736(13)60857-0 Goldstein, 2009, Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature, J. Clin. Psychiatry, 70, 1078, 10.4088/JCP.08r04505 Guloksuz, 2012, Evidence for an association between tumor necrosis factor-alpha levels and lithium response, J. Affect. Disord., 143, 148, 10.1016/j.jad.2012.04.044 Guloksuz, 2010, Cytokine levels in euthymic bipolar patients, J. Affect. Disord., 126, 458, 10.1016/j.jad.2010.04.027 Haack, 1999, Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis, J. Psychiatr. Res., 33, 407, 10.1016/S0022-3956(99)00021-7 Haarman, 2014, Relationship between clinical features and inflammation-related monocyte gene expression in bipolar disorder – towards a better understanding of psychoimmunological interactions, Bipolar Disord., 16, 137, 10.1111/bdi.12142 Harvey, 2002, Lithium salts in AIDS and AIDS-related dementia, Psychopharmacol. Bull., 36, 5 Himmerich, 2013, Impact of mood stabilizers and antiepileptic drugs on cytokine production in-vitro, J. Psychiatr. Res., 47, 1751, 10.1016/j.jpsychires.2013.07.026 Himmerich, 2014, Modulation of cytokine production by drugs with antiepileptic or mood stabilizer properties in anti-CD3- and anti-Cd40-stimulated blood in vitro, Oxid. Med. Cell. Longev., 2014, 806162, 10.1155/2014/806162 Himmerich, 2011, Impact of antipsychotics on cytokine production in-vitro, J. Psychiatr. Res., 45, 1358, 10.1016/j.jpsychires.2011.04.009 Hornig, 1998, Positive and negative acute phase proteins in affective subtypes, J. Affect. Disord., 49, 9, 10.1016/S0165-0327(97)00180-8 Ichiyama, 2000, Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB, Brain Res., 857, 246, 10.1016/S0006-8993(99)02439-7 Jope, 1999, Anti-bipolar therapy: mechanism of action of lithium, Mol. psychiatry, 4, 117, 10.1038/sj.mp.4000494 Kim, 2007, Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder, J. Affect. Disord., 104, 91, 10.1016/j.jad.2007.02.018 Kim, 2004, T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients, Psychiatry Res., 129, 267, 10.1016/j.psychres.2004.08.005 Kim, 2002, The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs, Mol. Psychiatry, 7, 1107, 10.1038/sj.mp.4001084 Kleinerman, 1989, Lithium chloride stimulates human monocytes to secrete tumor necrosis factor/cachectin, J. Leukoc. Biol., 46, 484, 10.1002/jlb.46.5.484 Knijff, 2007, An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment, Bipolar Disord., 9, 743, 10.1111/j.1399-5618.2007.00444.x Kronfol, 2000, Cytokines and the brain: implications for clinical psychiatry, Am. J. Psychiatry, 157, 683, 10.1176/appi.ajp.157.5.683 Lee, 2014, The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial, J. Clin. Psychopharmacol., 34, 337, 10.1097/JCP.0000000000000109 Leng, 2008, ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. The journals of gerontology, Ser. A Biol. Sci. Med. Sci., 63, 879 Levy, 2012, Functional outcome in bipolar disorder: the big picture, Depress. Res. Treat., 2012, 949248 Li, 2015, IL-23 and TGF-beta1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode, J. Affect. Disord., 174, 361, 10.1016/j.jad.2014.12.033 Liao, 2011, IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation, Curr. Opin. Immunol., 23, 598, 10.1016/j.coi.2011.08.003 Lieb, 1981, Immunopotentiation and inhibition of herpes virus activation during therapy with lithium carbonate, Med. Hypotheses, 7, 885, 10.1016/0306-9877(81)90043-8 Liu, 2004, Immunologic variables in acute mania of bipolar disorder, J. Neuroimmunol., 150, 116, 10.1016/j.jneuroim.2004.01.006 Maes, 1995, Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers, J. Psychiatr. Res., 29, 141, 10.1016/0022-3956(94)00049-W Maes, 1997, Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs, Psychiatry Res., 66, 1, 10.1016/S0165-1781(96)02915-0 Maes, 1995, The monocyte-T-lymphocyte hypothesis of major depression, Psychoneuroendocrinology, 20, 111, 10.1016/0306-4530(94)00066-J Maes, 1999, In vitro immunoregulatory effects of lithium in healthy volunteers, Psychopharmacology, 143, 401, 10.1007/s002130050965 Maletic, 2014, Integrated neurobiology of bipolar disorder, Front. Psychiatry, 5, 98, 10.3389/fpsyt.2014.00098 Miller, 2009, Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression, Biol. Psychiatry, 65, 732, 10.1016/j.biopsych.2008.11.029 Miller, 2011, Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects, Biol. Psychiatry, 70, 663, 10.1016/j.biopsych.2011.04.013 Mlodzikowska-Albrecht, 2007, Cytokines, epilepsy and epileptic drugs–is there a mutual influence?, Pharmacol. Rep.: PR, 59, 129 Modabbernia, 2013, Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies, Biol. Psychiatry, 74, 15, 10.1016/j.biopsych.2013.01.007 Moher, 2015, Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement, Syst. Rev., 4, 1, 10.1186/2046-4053-4-1 Moots, 1999, Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines, Ann. Rheum. Dis., 58, 585, 10.1136/ard.58.9.585 Munkholm, 2013, Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis, J. Psychiatr. Res., 47, 1119, 10.1016/j.jpsychires.2013.05.018 O’Connor, 2009, To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers, Brain Behav. Immun., 23, 887, 10.1016/j.bbi.2009.04.005 Ortiz-Dominguez, 2007, Immune variations in bipolar disorder: phasic differences, Bipolar Disord., 9, 596, 10.1111/j.1399-5618.2007.00493.x Padmos, 2008, A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes, Arch. Gen. Psychiatry, 65, 395, 10.1001/archpsyc.65.4.395 Petersein, 2015, Impact of lithium alone and in combination with antidepressants on cytokine production in vitro, J. neural Transm., 122, 109, 10.1007/s00702-014-1328-6 Petrini, 2012, Lithium in the treatment of neutropenia, Curr. Opin. Hematol., 19, 52, 10.1097/MOH.0b013e32834da93b Phillips, 2013, Bipolar disorder diagnosis: challenges and future directions, Lancet, 381, 1663, 10.1016/S0140-6736(13)60989-7 Rapaport, 1994, Immune parameters in euthymic bipolar patients and normal volunteers, J. Affect. Disord., 32, 149, 10.1016/0165-0327(94)90012-4 Rapaport, 1999, Immune parameters in rapid cycling bipolar patients before and after lithium treatment, J. Psychiatr. Res., 33, 335, 10.1016/S0022-3956(99)00007-2 Rapaport, 2001, The effects of lithium on ex vivo cytokine production, Biol. Psychiatry, 50, 217, 10.1016/S0006-3223(01)01144-1 Remlinger-Molenda, 2012, Selected cytokine profiles during remission in bipolar patients, Neuropsychobiology, 66, 193, 10.1159/000339949 Rosenblat, 2014, Inflamed moods: a review of the interactions between inflammation and mood disorders, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 10.1016/j.pnpbp.2014.01.013 Shabgah, 2014, Interleukin-17 in human inflammatory diseases, Postepy Dermatol. Alergol., 31, 256, 10.5114/pdia.2014.40954 Skinner, 1980, The effect of lithium chloride on the replication of herpes simplex virus, Med. Microbiol. Immunol., 168, 139, 10.1007/BF02121762 Sluzewska, 1997, Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression, Neuropsychobiology, 35, 123, 10.1159/000119332 Soares-Weiser, 2007, A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder, Health Technol. Assess., 11, 10.3310/hta11390 Stertz, 2013, Is bipolar disorder an inflammatory condition? The relevance of microglial activation, Curr. Opin. Psychiatry, 26, 19, 10.1097/YCO.0b013e32835aa4b4 Suda, 2013, Valproic acid attenuates ischemia-reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation, Eur. J. Pharmacol., 707, 26, 10.1016/j.ejphar.2013.03.020 Sugino, 2009, Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 33, 303, 10.1016/j.pnpbp.2008.12.006 Teixeira, 2015, Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment, Hum. Psychopharmacol., 30, 52, 10.1002/hup.2450 Tourjman, 2013, Antipsychotics’ effects on blood levels of cytokines in schizophrenia: a meta-analysis, Schizophr. Res., 151, 43, 10.1016/j.schres.2013.10.011 Tsai, 2003, Plasma levels of soluble transferrin receptors and Clara cell protein (CC16) during bipolar mania and subsequent remission, J. Psychiatr. Res., 37, 229, 10.1016/S0022-3956(02)00103-6 Tsai, 2001, Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania, J. Affect. Disord., 64, 185, 10.1016/S0165-0327(00)00252-4 Uyanik, 2015, Assessment of cytokine levels and hs-CRP in bipolar I disorder before and after treatment, Psychiatry Res., 228, 386, 10.1016/j.psychres.2015.05.078 Watanabe, 2014, Microarray analysis of global gene expression in leukocytes following lithium treatment, Hum. Psychopharmacol., 29, 190, 10.1002/hup.2381 Wolf, 2014, Interleukin-6 and its receptors: a highly regulated and dynamic system, Cytokine, 10.1016/j.cyto.2014.05.024 Xia, 1996, Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells, Immunopharmacology, 34, 27, 10.1016/0162-3109(96)00111-7 Yamamoto, 2016, Haloperidol Suppresses NF-kappaB to Inhibit Lipopolysaccharide-Induced Pro-Inflammatory Response in RAW 264 Cells. Medical science monitor, Int. Med. J. Exp. Clin. Res., 22, 367 Yatham, 2013, Canadian Network for Mood and Anxiety Treatments (CANMA)T) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update, Bipolar Disord., 15, 1, 10.1111/bdi.12025 Zhou, 2010, Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research, Curr. Opin. Clin. Nutr. Metab. Care, 13, 541, 10.1097/MCO.0b013e32833cf3bc